{
    "2019-11-03": [
        [
            {
                "time": "",
                "original_text": "流感大品种，九州通拿下独家总代！",
                "features": {
                    "keywords": [
                        "流感",
                        "大品种",
                        "九州通",
                        "独家总代"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "云南白药三季报探讨：业绩能否保持 第三大股东为何要减持 减持股份数量未明确",
                "features": {
                    "keywords": [
                        "云南白药",
                        "三季报",
                        "业绩",
                        "第三大股东",
                        "减持"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}